PROTARA THERAPEUTICS INC's ticker is TARA and the CUSIP is 74365U107. A total of 32 filers reported holding PROTARA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,081 | -48.5% | 13,821 | -26.3% | 0.00% | – |
| Q2 2023 | $44,817 | -14.1% | 18,752 | +11.4% | 0.00% | – |
| Q1 2023 | $52,186 | +115868.9% | 16,834 | 0.0% | 0.00% | – |
| Q4 2022 | $45 | -99.9% | 16,834 | +6.7% | 0.00% | – |
| Q3 2022 | $47,000 | -44.0% | 15,782 | -45.0% | 0.00% | – |
| Q2 2022 | $84,000 | -46.2% | 28,700 | -6.2% | 0.00% | – |
| Q1 2022 | $156,000 | -31.0% | 30,606 | -8.6% | 0.00% | – |
| Q4 2021 | $226,000 | – | 33,474 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 2,692,594 | $7,216,152 | 2.51% |
| Privium Fund Management (UK) Ltd | 119,730 | $320,876 | 0.24% |
| Ikarian Capital, LLC | 188,664 | $505,619 | 0.12% |
| Orbimed Advisors | 830,641 | $2,226,118 | 0.04% |
| Boxer Capital, LLC | 209,227 | $560,728 | 0.03% |
| Perceptive Advisors | 290,051 | $777,337 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 64,000 | $171,520 | 0.00% |
| Baker Brothers Advisors | 199,671 | $535,118 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 18,864 | $50,556 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 46,147 | $123,674 | 0.00% |